Matthews, Gail

Publishing since 1975 (Dinosaur)

Has published 97 publications in 36 years

Number of publications published per year by Matthews, Gail. (Source : PubMed)

Distribution of publications types for Matthews, Gail. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Crane M, Sirivichayakul S, Chang JJ, Avihingsanon A, Ubolyam S, Buranapraditkun S, Thantiworasit P, Wightman F, Locarnini S, Matthews G, Dore GJ, Ruxrungtham K, Lewin SR. No increase in hepatitis B virus (HBV)-specific CD8+ T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapy.  J. Virol.  2010;84;6  
•  Jin F, Prestage GP, Matthews G, Zablotska I, Rawstorne P, Kippax SC, Kaldor JM, Grulich AE. Prevalence, incidence and risk factors for hepatitis C in homosexual men: data from two cohorts of HIV-negative and HIV-positive men in Sydney, Australia.  Sex Transm Infect  2010;86;1  
•  Chang JJ, Sirivichayakul S, Avihingsanon A, Thompson AJ, Revill P, Iser D, Slavin J, Buranapraditkun S, Marks P, Matthews G, Cooper DA, Kent SJ, Cameron PU, Sasadeusz J, Desmond P, Locarnini S, Dore GJ, Ruxrungtham K, Lewin SR. Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection.  J. Virol.  2009;83;15  
•  Fletcher JP, Maclellan D, Gibbs H, Matthews G. Rational thromboprophylaxis in medical inpatients: not quite there yet. Comment.  Med. J. Aust.  2009;190;7  
•  Crane M, Oliver B, Matthews G, Avihingsanon A, Ubolyam S, Markovska V, Chang JJ, Dore GJ, Price P, Visvanathan K, French M, Ruxrungtham K, Lewin SR. Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy.  J. Infect. Dis.  2009;199;7  
•  Lewin SR, Ribeiro RM, Avihingsanon A, Bowden S, Matthews G, Marks P, Locarnini SA, Ruxrungtham K, Perelson AS, Dore GJ. Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1-hepatitis B virus coinfected individuals: similar effectiveness of lamivudine, tenofovir, or combination therapy.  Hepatology  2009;49;4  
•  Matthews G. New models for partnering with the business sector: an interview with Gene Matthews by Elizabeth Majestic.  Prev Chronic Dis  2009;6;2  
•  Preiss S, Littlejohn M, Angus P, Thompson A, Desmond P, Lewin SR, Sasadeusz J, Matthews G, Dore GJ, Shaw T, Sozzi V, Yuen L, Lau G, Ayres A, Thio C, Avihingsanon A, Ruxrungtham K, Locarnini S, Revill PA. Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance.  Hepatology  2008;48;3  
•  Crane M, Matthews G, Lewin SR. Hepatitis virus immune restoration disease of the liver.  Curr Opin HIV AIDS  2008;3;4  
•  Warm JS, Parasuraman R, Matthews G. Vigilance requires hard mental work and is stressful.  Hum Factors  2008;50;3  

[ See timeline ] [ See all publications ]